SCHEMBL23819047

SCHEMBL23819047

CO[C@](C#N)(CO[PH](=O)N[C@@H](C)C(=O)OCC1CCOCC1)[C@@H](OC(=O)C(C)C)[C@@H](CC(=O)C(C)C)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23819015 0.87 — —
SCHEMBL23819263 0.85 — —
SCHEMBL23819035 0.85 BTN3A1 (0.32) —
SCHEMBL23819033 0.83 — —
SCHEMBL26332594 0.81 — —
SCHEMBL26332277 0.81 RIPK1 (0.33) —
SCHEMBL26332563 0.81 RIPK1 (0.31) —
SCHEMBL23818680 0.80 — —
SCHEMBL23818691 0.79 — —
SCHEMBL23818990 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback